BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29111570)

  • 21. Influence of p53 (rs1625895) polymorphism in kidney transplant recipients.
    Azarpira N; Kazemi K; Darai M
    Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1160-5. PubMed ID: 25394431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Impacts of donor and recipient's SNP of cytokine and cytokine receptor on early acute renal allograft rejection].
    Guo YF; Tan JM; Li RY; Liu SZ; Li Y; Ying K; Xie Y; Mao YM
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3126-33. PubMed ID: 16405817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of natural killer (NK) receptors on NK (CD3-/CD56+), T (CD3+/CD56-) and NKT-like (CD3+/CD56+) cells after heart transplantation.
    Aguilar P; Mathieu CP; Clerc G; Ethevenot G; Fajraoui M; Mattei S; Faure GC; Bene MC
    J Heart Lung Transplant; 2006 Feb; 25(2):200-5. PubMed ID: 16446221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms With Acute Rejection in Liver Transplant Recipients.
    Azarpira N; Namazi S; Malahi S; Kazemi K
    Exp Clin Transplant; 2016 Jun; 14(3):307-12. PubMed ID: 26102207
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of CD86 gene polymorphism at +1057 position in liver transplant recipients.
    Marín LA; Moya-Quiles MR; Miras M; Muro M; Minguela A; Bermejo J; Ramírez P; García-Alonso AM; Parrilla P; Alvarez-López MR
    Transpl Immunol; 2005 Oct; 15(1):69-74. PubMed ID: 16223675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between TLR2, TLR4, and CD14 Gene Polymorphisms and Acute Rejection in Kidney Transplant.
    Abdolvahabi R; Sarrafnejad A; Nafar M; Jafari D; Razaghi E; Lessan-Pezashki M; Yekaninejad MS; Sharif-Paghaleh E; Amirzargar A
    Exp Clin Transplant; 2018 Feb; 16(1):31-37. PubMed ID: 28411360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recipient ctla-4 +49 G/G genotype is associated with reduced incidence of acute rejection after liver transplantation.
    de Reuver P; Pravica V; Hop W; Boor P; Metselaar HJ; Hutchinson IV; Tilanus HW; Kwekkeboom J
    Am J Transplant; 2003 Dec; 3(12):1587-94. PubMed ID: 14629291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokine gene polymorphisms and acute human liver graft rejection.
    Warlé MC; Farhan A; Metselaar HJ; Hop WC; Perrey C; Zondervan PE; Kap M; de Rave S; Kwekkeboom J; Ijzermans JN; Tilanus HW; Pravica V; Hutchinson IV; Bouma GJ
    Liver Transpl; 2002 Jul; 8(7):603-11. PubMed ID: 12089714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical significance of CD161+CD4+ T cells in the development of chronic antibody-mediated rejection in kidney transplant recipients.
    Kim KW; Kim BM; Doh KC; Kim CD; Jeong KH; Lee SH; Yang CW; Chung BH
    PLoS One; 2018; 13(7):e0200631. PubMed ID: 30011312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of TBX21, GATA3, and FOXP3 gene polymorphisms on acute cellular rejection after liver transplantation.
    Thude H; Tiede P; Sterneck M; Nashan B; Koch M
    HLA; 2019 Feb; 93(2-3):97-101. PubMed ID: 30614205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mannose-binding lectin-2 and ficolin-2 gene polymorphisms and clinical risk factors for acute rejection in kidney transplantation.
    Wu X; Wan Q; Ye Q; Zhou J
    Transpl Immunol; 2014 Mar; 30(2-3):71-5. PubMed ID: 24486561
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of association of recipient MCP-1 gene promoter polymorphism with acute graft rejection after orthotopic liver transplantation.
    Franco-López E; González-Escribano MF; Aguilera I; Pascasio JM; Pareja F; Bernardos A; Núñez-Roldán A
    Transplant Proc; 2005 Apr; 37(3):1496-8. PubMed ID: 15866653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms in the lectin pathway of complement activation influence the incidence of acute rejection and graft outcome after kidney transplantation.
    Golshayan D; Wójtowicz A; Bibert S; Pyndiah N; Manuel O; Binet I; Buhler LH; Huynh-Do U; Mueller T; Steiger J; Pascual M; Meylan P; Bochud PY;
    Kidney Int; 2016 Apr; 89(4):927-38. PubMed ID: 26924055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
    Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D receptor polymorphisms in liver transplant recipients.
    Azarpira N; Salahi H; Geramizadeh B; Daraie M
    Exp Clin Transplant; 2010 Dec; 8(4):314-7. PubMed ID: 21143098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the relationships between IL-23R, IL-17, IL-21 polymorphisms and serum level of IL-17, IL-21 with acute graft rejection in iranian liver transplant recipients.
    Karimi MH; Hejr S; Geramizadeh B; Nikeghbalian S; Kamali-Sarvestani E; Yaghobi R
    Immunol Invest; 2014; 43(1):69-85. PubMed ID: 24313807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor-alpha-308 G/A polymorphism and acute liver graft rejection: a meta-analysis.
    Liu F; Li B; Wei Y; Ma Y; Yan L; Wen T
    Transpl Immunol; 2010 Oct; 24(1):45-9. PubMed ID: 20888911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276.
    Yu X; Wei B; Su R; Yao J; Feng X; Jiang G; Xie H; Wu J; Xu X; Zhang M; Zheng S; Zhou L
    Mol Genet Genomic Med; 2019 Jun; 7(6):e689. PubMed ID: 31044564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor necrosis factor-alpha promoter polymorphisms and the risk of rejection after liver transplantation: a case control analysis of 210 donor-recipient pairs.
    Jazrawi SF; Zaman A; Muhammad Z; Rabkin JM; Corless CL; Olyaei A; Biggs A; Ham J; Chou S; Rosen HR
    Liver Transpl; 2003 Apr; 9(4):377-82. PubMed ID: 12682890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of association between the -403G/A promoter polymorphism in the human CCL5/RANTES chemokine gene in liver transplant outcome.
    Botella C; Marín L; Moya-Quiles R; Miras M; Sánchez-Bueno F; Minguela A; Bermejo J; Parrilla P; Alvarez-López R; Muro M
    Transpl Int; 2006 Feb; 19(2):98-104. PubMed ID: 16441357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.